By integrating laboratory parameters, including plasma EBV-DNA and IFN-γ, we constructed a multivariate model that significantly improved differential accuracy and offered better predictive value for poor prognosis compared to the lymphoma diagnosis. The gene discussed is IFNG; the disease is lymphoma.